8% Growth in Asia Pacific Presents Pharma Investors with Good Opportunities
The Asia Pacific market for drugs to treat all medical conditions will be worth $255 billion in 2020, having grown from $185 billion in 2016. By 2020 the Asia Pacific market, which was already in 2016 the second largest in the world after North America, will have increased its lead over Western Europe in third place and made gains on North America.
View full press release